Mutations in multiple PKD genes may explain early and severe polycystic kidney disease.
Where this comes from
- Record sourced from PubMed, PMID 22034641.
- Also identified by DOI 10.1681/ASN.2010101080 and PMC identifier 3279997.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Autosomal dominant polycystic kidney disease (ADPKD) is typically a late-onset disease caused by mutations in PKD1 or PKD2, but about 2% of patients with ADPKD show an early and severe phenotype that can be clinically indistinguishable from autosomal recessive polycystic kidney disease (ARPKD). The high recurrence risk in pedigrees with early and severe PKD strongly suggests a common familial modifying background, but the mechanisms underlying the extensive phenotypic variability observed among affected family members remain unknown. Here, we describe severely affected patients with PKD who carry, in addition to their expected familial germ-line defect, additional mutations in PKD genes, including HNF-1β, which likely aggravate the phenotype. Our findings are consistent with a common pathogenesis and dosage theory for PKD and may propose a general concept for the modification of disease expression in other so-called monogenic disorders.
Medical subject headings
- Aryl Hydrocarbon Receptor Nuclear Translocator
- Polycystic Kidney, Autosomal Dominant
- Severity of Illness Index
- TRPP Cation Channels